Neoadjuvant multidrug chemotherapy including High-Dose Methotrexate modifies VEGF expression in Osteosarcoma: an immunohistochemical analysis

被引：0
|
作者：
Barbara Rossi
Giovanni Schinzari
Giulio Maccauro
Laura Scaramuzzo
Diego Signorelli
Michele A Rosa
Carlo Fabbriciani
Barone Carlo
机构：
[1] Catholic University,Department of Orthopaedics and Traumatology
[2] Agostino Gemelli Hospital,Department of Medical Oncology
[3] Catholic University,Department of Orthopaedics
[4] Agostino Gemelli Hospital,undefined
[5] Messina University,undefined
来源：
BMC Musculoskeletal Disorders | / 11卷
关键词：
Vascular Endothelial Growth Factor; Osteosarcoma; Vascular Endothelial Growth Factor Expression; Local Relapse; High Grade Osteosarcoma;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Neoadjuvant multidrug chemotherapy including High-Dose Methotrexate modifies VEGF expression in Osteosarcoma: an immunohistochemical analysis
    Rossi, Barbara
    Schinzari, Giovanni
    Maccauro, Giulio
    Scaramuzzo, Laura
    Signorelli, Diego
    Rosa, Michele A.
    Fabbriciani, Carlo
    Carlo, Barone
    BMC MUSCULOSKELETAL DISORDERS, 2010, 11
  • [2] Neoadjuvant chemotherapy with high-dose methotrexate in osteosarcoma
    Mir, Olivier
    Ropert, Stanislas
    Goldwasser, Francois
    LANCET ONCOLOGY, 2008, 9 (12): : 1198 - 1198
  • [3] Clinical analysis of osteosarcoma patients treated with high-dose methotrexate-free neoadjuvant chemotherapy
    Xu, M.
    Xu, F.
    Yu, C.
    CURRENT ONCOLOGY, 2014, 21 (05) : E678 - E684
  • [4] A survival analysis and treatment outcomes of 131 cases of osteosarcoma treated with high-dose methotrexate multidrug chemotherapy
    Xu, Ye-Feng
    Jiang, Shen-Jun
    Wang, Yi-Qing
    Yao, Yong-Wei
    Liu, Yun-Xia
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (05): : 8465 - 8473
  • [5] THE IMPORTANCE OF DOSE-INTENSITY IN NEOADJUVANT CHEMOTHERAPY OF OSTEOSARCOMA - A RETROSPECTIVE ANALYSIS OF HIGH-DOSE METHOTREXATE, CISPLATINUM AND ADRIAMYCIN USED PREOPERATIVELY
    BACCI, G
    PICCI, P
    AVELLA, M
    DALLARI, D
    FERRARI, S
    PRASAD, R
    DISCIOSCIO, M
    MALAGUTI, C
    CALDORA, P
    JOURNAL OF CHEMOTHERAPY, 1990, 2 (02) : 127 - 135
  • [6] Perioperative chemotherapy with and without high-dose methotrexate in adult osteosarcoma
    Negrao, Marcelo Vailati
    da Silva Rocha, Lucila S.
    Girardi, Daniel da Motta
    Feher, Olavo
    ANTI-CANCER DRUGS, 2017, 28 (08) : 915 - 921
  • [7] High-dose methotrexate in fibroblastic osteosarcoma
    Chowbay, B
    Siong, KK
    ANNALS OF PHARMACOTHERAPY, 2001, 35 (12) : 1669 - 1669
  • [8] Pharmacokinetic Individualization of High-Dose Methotrexate Chemotherapy for the Treatment of Localized Osteosarcoma
    Fujita, Y.
    Nakamura, T.
    Aomori, T.
    Nishiba, H.
    Shinozaki, T.
    Yanagawa, T.
    Takagishi, K.
    Watanabe, H.
    Okada, Y.
    Nakamura, K.
    Horiuchi, R.
    Yamamoto, K.
    JOURNAL OF CHEMOTHERAPY, 2010, 22 (03) : 186 - 190
  • [9] Chemotherapy for osteosarcoma without high-dose methotrexate: Another piece in the puzzle
    Blay, Jean-Yves
    ONKOLOGIE, 2007, 30 (05): : 226 - 227
  • [10] Nomogram predicting leukopenia in osteosarcoma after high-dose methotrexate chemotherapy
    Wu, Haixiao
    Xu, Guijun
    Li, Zhijun
    Xu, Yao
    Lin, Yile
    Chekhonin, Vladimir P.
    Peltzer, Karl
    Wang, Jun
    Li, Shu
    Li, Huiyang
    Zhang, Jin
    Xue, Yuan
    Ma, Wenjuan
    Wang, Xin
    Zhang, Chao
    AGING-US, 2022, 14 (12): : 5023 - 5033
12345